Erlotinib Hydrochloride Clinical Trials

1 actively recruiting trial across 1 location

Also known as: CP 358, CP-358, CP358, Cp-358,774, OSI 774, OSI-774, OSI774, Tarceva

Filter by location:

Rochester, Minnesota1 trial

Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Oral Cavity Cancer in a Rural Midwest United States Population

Mayo Clinic in Rochester

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.